Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
3600 participants
OBSERVATIONAL
2020-10-04
2041-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Collection of Samples for Urothelial Cancer of Bladder
NCT04167332
Prospective Sample Collection for Cancer of Bladder
NCT03973671
Evaluating Bladder CARE™, a New Non-Invasive Urine Test, for Bladder Cancer Detection in Inconclusive Cases
NCT06870253
The Cxbladder Rule-out of Recurrent Urothelial Carcinoma
NCT03673202
Bladder Bank (a Prospective Banking Study)
NCT06109857
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bladder cancer patients
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Any stage except Ta
* 18 years or older
* Written informed consent
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Prospective Bladder Cancer Infrastructure Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jeroen Bosch Hospital
's-Hertogenbosch, , Netherlands
ZGT
Almelo, , Netherlands
Meander Medical Center
Amersfoort, , Netherlands
Amsterdam UMC, location VUMC
Amsterdam, , Netherlands
Rijnstate
Arnhem, , Netherlands
Amphia Ziekenhuis
Breda, , Netherlands
Albert Schweitzer Hospital
Dordrecht, , Netherlands
Ziekenhuis Gelderse Vallei
Ede, , Netherlands
Treant Hospital
Emmen, , Netherlands
University Medical Center Groningen
Groningen, , Netherlands
Spaarne Gasthuis
Hoofddorp, , Netherlands
Medisch Centrum Leeuwarden
Leeuwarden, , Netherlands
Alrijne Ziekenhuis
Leiderdorp, , Netherlands
Maastricht University Medical Center
Maastricht, , Netherlands
Canisius Wilhelmina Ziekenhuis
Nijmegen, , Netherlands
Radboud univerisity Medical Center
Nijmegen, , Netherlands
Erasmus Medical Center
Rotterdam, , Netherlands
Zuyderland
Sittard, , Netherlands
Elisabeth-TweeSteden Ziekenhuis
Tilburg, , Netherlands
University Medical Center Utrecht
Utrecht, , Netherlands
VieCuri
Venlo, , Netherlands
SKB Winterswijk
Winterswijk, , Netherlands
Isala
Zwolle, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Richters A, Meijer RP, Mehra N, Boormans JL, van der Heijden AG, van der Heijden MS, Kiemeney LA, Aben KK. Prospective bladder cancer infrastructure for experimental and observational research on bladder cancer: study protocol for the 'trials within cohorts' study ProBCI. BMJ Open. 2021 May 18;11(5):e047256. doi: 10.1136/bmjopen-2020-047256.
Richters A, Mehra N, Meijer RP, Boormans JL, van der Heijden AG, Smilde TJ, van der Heijden MS, Kiemeney LA, Aben KK. Utilization of systemic treatment for metastatic bladder cancer in everyday practice: Results of a nation-wide population-based cohort study. Cancer Treat Res Commun. 2020;25:100266. doi: 10.1016/j.ctarc.2020.100266. Epub 2020 Dec 8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ProBCI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.